表紙:膝手術・人工膝関節向け疼痛管理治療薬の世界市場 - 薬剤別・流通チャネル別・地域別:市場規模・シェア・将来展望・機会分析 (2022年~2030年)
市場調査レポート
商品コード
1073635

膝手術・人工膝関節向け疼痛管理治療薬の世界市場 - 薬剤別・流通チャネル別・地域別:市場規模・シェア・将来展望・機会分析 (2022年~2030年)

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, by Drug, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 177 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
膝手術・人工膝関節向け疼痛管理治療薬の世界市場 - 薬剤別・流通チャネル別・地域別:市場規模・シェア・将来展望・機会分析 (2022年~2030年)
出版日: 2022年04月08日
発行: Coherent Market Insights
ページ情報: 英文 177 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の膝手術・人工膝関節向け疼痛管理治療薬市場の主な促進要因として、大手企業の製品開発・上市に向けた研究開発活動の拡大や、薬剤の承認件数の増加、膝関節全置換術の増加などが挙げられます。

当レポートでは、世界の膝手術・人工膝関節向け疼痛管理治療薬の市場について分析し、製品の概要や、市場の基本構造および促進・抑制要因、新型コロナウイルス感染症 (COVID-19) の影響、薬剤別・流通チャネル別・地域別の市場動向の見通し、主要企業のプロファイル・市場シェアなどを調査しております。

目次

第1章 分析目的・前提条件

第2章 市場概略

  • 分析概要
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • COM (Coherent Opportunity Map)

第3章 市場の力学・規制・動向の分析

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 影響度の分析
  • 膝関節全置換術の実施件数
  • 近年の主な動き
  • 規制シナリオ
  • PEST分析
  • パイプライン分析
  • 膝関節全置換術のための術後疼痛管理レジーム:概要

第4章 世界の膝手術・人工膝関節向け疼痛管理治療薬市場:新型コロナウイルス感染症 (COVID-19) 感染拡大の影響

  • COVID-19の疫学
  • 医療への全体的な影響
  • 需要・供給への影響の分析

第5章 世界の膝手術・人工膝関節向け疼痛管理治療薬市場:薬剤別 (単位:100万米ドル、2017年~2030年)

  • イントロダクション
  • アセトアミノフェン
  • COX-2阻害剤
  • オピオイド
  • 非ステロイド性抗炎症薬 (NSAID)
  • ケタミン
  • その他

第6章 世界の膝手術・人工膝関節向け疼痛管理治療薬市場:流通チャネル別 (単位:100万米ドル、2017年~2030年)

  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第7章 世界の膝手術・人工膝関節向け疼痛管理治療薬市場:地域別 (単位:100万米ドル、2017年~2030年)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第8章 競合情勢

  • 競合スナップショット
    • Pfizer Inc
    • Allay Therapeutics
    • Mallinckrodt
    • Johnson & Johnson
    • Zydus Cadila Healthcare Ltd.
    • Novartis AG
    • Purdue Pharma
    • Delphis Pharmaceutical
    • Taj Pharmaceuticals Limited
    • GlaxoSmithKline plc
    • AbbVie Inc
    • Aurobindo Pharma

第9章 付録

目次
Product Code: CMI4998

Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.

Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period

For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.

Market Dynamics

Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.

For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay's first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.

Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.

Key features of the study:

  • This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market

Detailed Segmentation:

  • Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Drug:
  • Acetaminophen
  • COX-2 inhibitors
  • Opioids
  • Non-steroidal Anti-inflammatories
  • Ketamine
  • Others
  • Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Knee Surgeries And Arthroplasty Pain Management Therapeutics Market, By Region:
  • North America
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Drug
    • Acetaminophen
    • COX-2 inhibitors
    • Opioids
    • Non-steroidal Anti-inflammatories
    • Ketamine
    • Others
    • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc*
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Allay Therapeutics
    • Mallinckrodt
    • Johnson & Johnson
    • Zydus Cadila Healthcare Ltd.
    • Novartis AG
    • Purdue Pharma
    • Delphis Pharmaceutical
    • Taj Pharmaceuticals Limited
    • GlaxoSmithKline plc
    • AbbVie Inc
    • Aurobindo Pharma

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Number of Total Knee Arthroplasty Surgeries
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • Pipeline Analysis
  • Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty

4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Overall Impact On Healthcare
  • Impact On Demand And Supply Analysis

5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Acetaminophen
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • COX-2 inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Opioids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Non-steroidal Anti-inflammatories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Ketamine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
  • North America
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Drug, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Competitive Snapshot
    • Pfizer Inc*
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Allay Therapeutics
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mallinckrodt
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Zydus Cadila Healthcare Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Purdue Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Delphis Pharmaceutical
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Taj Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AbbVie Inc
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Aurobindo Pharma
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact